InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,870.62
(
-1.32%
)
US TECH 100
19,884.00
(
-2.28%
)
Dow Jones
43,444.99
(
-0.70%
)
Brent Oil
70.90
(
0.00%
)
Bitcoin
91,453.83
(
0.44%
)
Post# of 253623
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

palindromy

Send PM Follow Ignore
Followers 4
Posts 712
Boards Moderated 0
Alias Born 12/16/2006

palindromy

Re: DewDiligence post# 68287

Saturday, 01/17/2009 3:43:01 AM

Saturday, January 17, 2009 3:43:01 AM

Post# of 253623
Could there be other partners looking at the possibility of Truvada becoming generic by the time IDX899 actually can get to market? If this is the case, then IDX899 could be a franchise saver for Gild and perhaps a franchise breaker for somebody else seriously interested in the space. Just speculation since I am not even sure when the patents run out on Truvada. However, this article - http://finance.yahoo.com/news/Gilead-says-Teva-asks-for-apf-13583988.html - suggests that Teva at least is challenging the two longest dated patents and the rest perhaps expire much faster.

Regds
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up